Transpupillary collagen photocrosslinking for targeted modulation of ocular biomechanics

The central vision-threatening event in glaucoma is dysfunction and loss of retinal ganglion cells (RGCs), thought to be promoted by local tissue deformations. Here, we sought to reduce tissue deformation near the optic nerve head by selectively stiffening the peripapillary sclera, i.e. the scleral...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomaterials 2021-04, Vol.271 (C), p.120735-120735, Article 120735
Hauptverfasser: Gerberich, B.G., Hannon, B.G., Hejri, A., Winger, E.J., Schrader Echeverri, E., Nichols, L.M., Gersch, H.G., MacLeod, N.A., Gupta, S., Read, A.T., Ritch, M.D., Sridhar, S., Toothman, M.G., Gershon, G.S., Schwaner, S.A., Sánchez-Rodríguez, G., Goyal, V., Toporek, A.M., Feola, A.J., Grossniklaus, H.E., Pardue, M.T., Ethier, C.R., Prausnitz, M.R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The central vision-threatening event in glaucoma is dysfunction and loss of retinal ganglion cells (RGCs), thought to be promoted by local tissue deformations. Here, we sought to reduce tissue deformation near the optic nerve head by selectively stiffening the peripapillary sclera, i.e. the scleral region immediately adjacent to the optic nerve head. Previous scleral stiffening studies to treat glaucoma or myopia have used either pan-scleral stiffening (not regionally selective) or regionally selective stiffening with limited access to the posterior globe. We present a method for selectively stiffening the peripapillary sclera using a transpupillary annular light beam to activate methylene blue administered by retrobulbar injection. Unlike prior approaches to photocrosslinking in the eye, this approach avoids the damaging effects of ultraviolet light by employing red light. This targeted photocrosslinking approach successfully stiffened the peripapillary sclera at 6 weeks post-treatment, as measured by whole globe inflation testing. Specifically, strain was reduced by 47% when comparing treated vs. untreated sclera within the same eye (n = 7, p=0.0064) and by 54% when comparing the peripapillary sclera of treated vs. untreated eyes (n = 7, p
ISSN:0142-9612
1878-5905
DOI:10.1016/j.biomaterials.2021.120735